Adverse drug reactions (ADRs) to antibiotics are commonly reported among children and young people. Allergic mechanisms are frequently suspected and alternative agents routinely prescribed. Altered ...

CPSC recalls over 2,000 Benadryl bottles for failing child safety packaging standards, warning of poisoning hazards.

In a recent debate in the House of Lords it was discussed that moving young people out of the ... shared her experience of working in a children's allergy clinic in London for that debate and ...

It found “early childhood exposure to peanut decreases the risk of developing a peanut allergy”, and identified an 81 percent reduction in peanut allergy among five-year-old children who ...

The Chiang Mai smoke crisis continues, impacting public health, especially children, with many suffering from nosebleeds and allergies, resulting in rashes.

Opens in a new tab or window The FDA expanded the approval of a sublingual immunotherapy (SLIT; Odactra) for treating house dust mite allergies in young children, drugmaker ALK announced.

And based on early results from this clinical trial, the FDA approved omalizumab as a treatment for food allergies in adults and children as young as 1 year old, researchers said in background notes.

ALK (ALKB:DC / OMX: ALK B) today announced that the US Food and Drug Administration (FDA) has approved ALK’s ODACTRA ® tablet for use in young children with house dust mite (HDM) allergy.

And based on early results from this clinical trial, the FDA approved omalizumab as a treatment for food allergies in adults and children as young as 1 year old, researchers said in background notes.

ALK (ALKB:DC / OMX: ALK B) today announced that the US Food and Drug Administration (FDA) has approved ALK’s ODACTRA ® tablet for use in young children with house dust mite (HDM) allergy. ODACTRA ® is ...